Exjade-Early-Trial

计划入组 2 人 · 首次发布于 2010 年 1 月 28 日

Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)

计划入组 24 人 · 首次发布于 2016 年 6 月 29 日

Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study

计划入组 24 人 · 首次发布于 2013 年 8 月 1 日

CART-meso(Novartis Pharma)

SQZ-622(Novartis Pharma)

LLG-783

OBS PAKISTAN (PRIVATE) LIMITED

Pakistan

IRD PAKISTAN (PRIVATE) LIMITED

Pakistan

Novartis Pharma AG

Australia

CCP Approves Getz Group's Acquisition of Novartis Pakistan in Major Pharmaceutical Transaction

Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial

Pakistan's DRAP Launches E-Reporting System for Drug Adverse Reactions